Literature DB >> 8120219

Leukocyte myeloperoxidase and salivary lactoperoxidase: identification and quantitation in human mixed saliva.

E L Thomas1, M M Jefferson, R E Joyner, G S Cook, C C King.   

Abstract

Human salivary lactoperoxidase (HS-LP) is synthesized and secreted by the salivary glands, whereas myeloperoxidase (MPO) is found in PMN leukocytes, which migrate into the oral cavity at gingival crevices. HS-LP levels vary with changes in salivary gland function, but increased numbers of MPO-containing leukocytes indicate infection or inflammation of oral tissues. To determine the contribution of each enzyme to the peroxidase activity of mixed-saliva samples, activity was assayed at pH 5.4 with tetramethylbenzidine as the substrate, with and without the inhibitor dapsone (4,4'-diaminodiphenylsulfone). Dapsone blocked the activity of HS-LP but not MPO. The enzymes were also separated and partially purified from the soluble portion of saliva samples and from detergent extracts of the saliva sediment. Chromatographic properties of the proteins were similar to those of LP from bovine milk (BM-LP) and MPO from human leukocytes. The identity and amounts of the enzymes were confirmed by the absorption spectra and by immunoblotting with antibodies to BM-LP and human MPO. Eosinophil peroxidase (EPO), a distinct enzyme found in eosinophilic leukocytes, was not detected by chromatography or with antibodies to human EPO. On average, 75% of the activity in samples from normal donors was due to MPO and 25% to HS-LP. When corrected for the lower specific activity of HS-LP in this assay, the average amount of MPO (3.6 micrograms/mL) was twice the amount of HS-LP (1.9 micrograms/mL). The amount of MPO corresponded to 1 x 10(6) PMN leukocytes/mL of saliva. The enzymes were distributed differently: Eighty-nine percent of the HS-LP was in the soluble portion of saliva, and 78% of the MPO was in the sediment, which contained 51% of the total activity. In contrast to results obtained with PMN leukocytes from blood, detergent was not required for MPO activity to be measured in saliva, indicating that the enzyme was accessible to peroxidase substrates. The results indicate that MPO is responsible for a large portion of peroxidase-catalyzed reactions in mixed saliva. The unique function of HS-LP may be carried out within the salivary glands, prior to secretion into the oral cavity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8120219     DOI: 10.1177/00220345940730021001

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  18 in total

1.  Airway peroxidases catalyze nitration of the {beta}2-agonist salbutamol and decrease its pharmacological activity.

Authors:  Krzysztof J Reszka; Larry Sallans; Stephen Macha; Kari Brown; Dennis W McGraw; Melinda Butsch Kovacic; Bradley E Britigan
Journal:  J Pharmacol Exp Ther       Date:  2010-10-25       Impact factor: 4.030

2.  Enhancement of respiratory mucosal antiviral defenses by the oxidation of iodide.

Authors:  Anthony J Fischer; Nicholas J Lennemann; Sateesh Krishnamurthy; Péter Pócza; Lakshmi Durairaj; Janice L Launspach; Bethany A Rhein; Christine Wohlford-Lenane; Daniel Lorentzen; Botond Bánfi; Paul B McCray
Journal:  Am J Respir Cell Mol Biol       Date:  2011-03-25       Impact factor: 6.914

3.  Uric acid and thiocyanate as competing substrates of lactoperoxidase.

Authors:  Antonia Seidel; Heather Parker; Rufus Turner; Nina Dickerhof; Irada S Khalilova; Sigurd M Wilbanks; Anthony J Kettle; Guy N L Jameson
Journal:  J Biol Chem       Date:  2014-06-13       Impact factor: 5.157

4.  Evaluation of thiol-based antioxidant therapeutics in cystic fibrosis sputum: Focus on myeloperoxidase.

Authors:  Vihas T Vasu; Sharon J de Cruz; Jessica S Houghton; Keri A Hayakawa; Brian M Morrissey; Carroll E Cross; Jason P Eiserich
Journal:  Free Radic Res       Date:  2010-10-18

5.  Myeloperoxidase-dependent oxidative metabolism of nitric oxide in the cystic fibrosis airway.

Authors:  Anna L P Chapman; Brian M Morrissey; Vihas T Vasu; Maya M Juarez; Jessica S Houghton; Chin-Shang Li; Carroll E Cross; Jason P Eiserich
Journal:  J Cyst Fibros       Date:  2010-01-15       Impact factor: 5.482

6.  Peroxidative metabolism of beta2-agonists salbutamol and fenoterol and their analogues.

Authors:  Krzysztof J Reszka; Dennis W McGraw; Bradley E Britigan
Journal:  Chem Res Toxicol       Date:  2009-06       Impact factor: 3.739

7.  Inducible nitric oxide synthase increases secretion from inflamed salivary glands.

Authors:  Patricia N Correia; Guy H Carpenter; Katherine L Paterson; Gordon B Proctor
Journal:  Rheumatology (Oxford)       Date:  2009-11-20       Impact factor: 7.580

8.  Effect of lactoperoxidase on the antimicrobial effectiveness of the thiocyanate hydrogen peroxide combination in a quantitative suspension test.

Authors:  A Welk; Ch Meller; R Schubert; Ch Schwahn; A Kramer; H Below
Journal:  BMC Microbiol       Date:  2009-07-09       Impact factor: 3.605

9.  Acute salivary gland hypofunction in the duct ligation model in the absence of inflammation.

Authors:  P N Correia; G H Carpenter; S M Osailan; K L Paterson; G B Proctor
Journal:  Oral Dis       Date:  2008-01-22       Impact factor: 3.511

10.  Effect of nonsurgical periodontal therapy on salivary myeloperoxidase levels: A biochemical study.

Authors:  Mona Dagar; Dhruv Kumar Deepa; Madan Molly; Anamika Sharma; Braham Prakash Khattak
Journal:  J Indian Soc Periodontol       Date:  2015 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.